Mechanisms of Fluoroquinolone Resistance: An Update 1994–1998 Laura J. V. Piddock Oral Presentations 01 December 2012 Pages: 11 - 18
Activity of Quinolones Against Mycobacteria Michael R. Jacobs Oral Presentations 01 December 2012 Pages: 19 - 22
Activity of Newer Fluoroquinolones In Vitro Against Gram-Positive Bacteria George M. Eliopoulos Oral Presentations 01 December 2012 Pages: 23 - 28
Pharmacokinetics and Pharmacodynamics of Fluoroquinolones John Turnidge Oral Presentations 01 December 2012 Pages: 29 - 36
Fluoroquinolones in Paediatrics Hasan S. JafriGeorge H. McCracken Jr Oral Presentations 01 December 2012 Pages: 43 - 48
Quinolones in the Treatment of Typhoid Fever H. Erdal Akalin Oral Presentations 01 December 2012 Pages: 52 - 54
Quinolone Use in the Developing World Thelma E. Tupasi Oral Presentations 01 December 2012 Pages: 55 - 59
Quinolone Activity Against Anaerobes Peter C. Appelbaum Oral Presentations 01 December 2012 Pages: 60 - 64
Effect of Quinolones on Intestinal Ecology Charlotta EdlundCarl Erik Nord Oral Presentations 01 December 2012 Pages: 65 - 70
Cost Effectiveness of Quinolones in Hospitals and the Community Peter Davey Oral Presentations 01 December 2012 Pages: 71 - 77
Activity of Quinolones Against Chlamydia pneumoniae Margaret R. Hammerschlag Oral Presentations 01 December 2012 Pages: 78 - 81
Fluoroquinolone Treatment of Skin and Skin Structure Infections Adolf W. Karchmer Oral Presentations 01 December 2012 Pages: 82 - 84
Use of Quinolones in Osteomyelitis and Infected Orthopaedic Prosthesis Daniel P. LewFrancis A. Waldvogel Oral Presentations 01 December 2012 Pages: 85 - 91
Quinolones in Sexually Transmitted Diseases Geoffrey L. Ridgway Oral Presentations 01 December 2012 Pages: 92 - 95
Newer Quinolones in the Long Term Prophylaxis of Recurrent Urinary Tract Infections (UTI) Silvester KrcméryJuraj HromecDusan Gulla Oral Presentations 01 December 2012 Pages: 99 - 102
Outcome of Antibiotic Therapy with Ciprofloxacin in Chronic Bacterial Prostatitis Wolfgang WeidnerMartin LudwigHans Gerd Schiefer Oral Presentations 01 December 2012 Pages: 103 - 106
Antimicrobial Activity of Gatifloxacin Against Campylobacter jejuni and Anaerobic Bacteria M. E. ErwinR. N. JonesG. V. Doern Poster Presentations 01 December 2012 Pages: 107 - 109
Antianaerobic Activity of Grepafloxacin Compared with Ofloxacin, Ciprofloxacin, Clindamycin, Metronidazole and 5 β-Lactams Luc DubreuilE. SingerF. Leblanc Poster Presentations 01 December 2012 Pages: 110 - 112
Antianaerobic Activity of Gatifloxacin Lois M. EdnieMichael R. JacobsPeter C. Appelbaum Poster Presentations 01 December 2012 Pages: 113 - 110
Grepafloxacin vs Pneumococci Resistant to Fluoroquinolones by a Putative Efflux Mechanism Nigel P. BrenwaldMartin J. GillRichard Wise Poster Presentations 01 December 2012 Pages: 117 - 118
Mutations to Quinolone Resistance in Pseudomonas aeruginosa and Enterococcus faecium Shah JalalNagwa El AminBengt Wretlind Poster Presentations 01 December 2012 Pages: 119 - 120
Activity of Trovafloxacin Against Topoisomerases and GyrA/Gr1A Mutants of Staphylococcus aureus Thomas D. GootzRichard P. ZaniewskiAlison E. Maurice Poster Presentations 01 December 2012 Pages: 121 - 122
Ofloxacin Selects First-Step ParC Mutations in Mycoplasma hominis Whereas Sparfloxacin Selects for First-Step GyrA Mutations G. E. KennyP. A. YoungW. M. Huang Poster Presentations 01 December 2012 Pages: 123 - 124
Fluoroquinolone Resistance Mutations in the DNA Topoisomerase II Genes of Viridans Group Streptococci Clinical Isolates Delia BalasIrene GonzálezAdela G. De La Campa Poster Presentations 01 December 2012 Pages: 125 - 127
Nosocomial Superinfections with Gram-Negative Pathogens and Quinolone Resistance after Treatment with Ciprofloxacin vs Ofloxacin Yehuda CarmeliMatthew H. Samore Poster Presentations 01 December 2012 Pages: 128 - 129
Resistant Mutants of Staphylococcus aureus with Ofloxacin in Comparison with Ciprofloxacin Y. RioF. JurinJ. Didion Poster Presentations 01 December 2012 Pages: 130 - 131
Mechanisms and Frequency of Resistance to Moxifloxacin in Comparison with Ciprofloxacin in Staphylococcus aureus Dilek InceRahul ArasDavid C. Hooper Poster Presentations 01 December 2012 Pages: 132 - 133
Mechanisms and Frequency of Resistance to Gatifloxacin in Comparison with Ciprofloxacin in Staphylococcus aureus Dilek InceRahul ArasDavid C. Hooper Poster Presentations 01 December 2012 Pages: 134 - 135
Mutational Resistance to Quinolones in Staphylococci Kenneth S. ThomsonEllen S. MolandChristine C. Sanders Poster Presentations 01 December 2012 Pages: 136 - 137
Comparative In Vitro Activity of Grepafloxacin Against Selected Mutants and Clinical Isolates C. J. SoussyF. Leblanc Poster Presentations 01 December 2012 Pages: 138 - 140
Synergistic Activity of Trovafloxacin with Other Agents Melissa A. VisalliSaralee BajaksouzianPeter C. Appelbaum Poster Presentations 01 December 2012 Pages: 141 - 143
Antimicrobial Activity of Moxifloxacin and Levofloxacin Photodegradation Products C. M. TobinJ. SunderlandL. O. White Poster Presentations 01 December 2012 Pages: 144 - 145
Comparative Postantibiotic Effect of Sitafloxacin and Trovafloxacin on Methicillin-Resistant Staphylococcus aureus E. J. Giamarellos-BourboulisP. GreckaH. Giamarellou Poster Presentations 01 December 2012 Pages: 146 - 148
Synergistic In Vitro Activity of Clinafloxacin M. B. PerriM. J. Zervos Poster Presentations 01 December 2012 Pages: 149 - 150
Comparative Antibiotic Activity Versus Vancomycin Intermediate-Susceptible Staphylococcus aureus M. D. HubandM. A. CohenS. R. VanderRoest Poster Presentations 01 December 2012 Pages: 151 - 153
Activity of Trovafloxacin Against Micro-Organisms Isolated from Diabetic Patients with Lower Extremity Infections K. WeissM. LaverdièreL. Poirier Poster Presentations 01 December 2012 Pages: 154 - 155
Antistaphylococcal Activity of Moxifloxacin A. Dalhoff Poster Presentations 01 December 2012 Pages: 160 - 161
Antimicrobial Activity of Gatifloxacin Tested Against 1676 Gram-Positive Cocci Resistant to Ciprofloxacin R. N. JonesM. A. PfallerThe SENTRY Participants Group Poster Presentations 01 December 2012 Pages: 162 - 163
Antistreptococcal Activity of Gatifloxacin Ronald N. JonesDavid M. JohnsonDouglas J. Biedenbach Poster Presentations 01 December 2012 Pages: 164 - 166
Antibacterial Activity of Gatifloxacin in Obstetrics and Gynaecology Koji IzumiHiroshige MikamoTeruhiko Tamaya Poster Presentations 01 December 2012 Pages: 166 - 168
In Vitro Antibacterial Activities of Gatifloxacin (AM-1155) Against Clinical Pathogens Recently Isolated from Various Infections Youko TsurumakiHinako MandaYasuo Oomori Poster Presentations 01 December 2012 Pages: 169 - 170
Ofloxacin Photodegradation Products Possess Antimicrobial Activity J. SunderlandC. M. TobinA. J. Hedges Poster Presentations 01 December 2012 Pages: 171 - 172
Antimicrobial Spectrum of Gatifloxacin in the SENTRY Program R. N. JonesM. A. Pfallerthe SENTRY Participant Group Poster Presentations 01 December 2012 Pages: 173 - 175
Gatifloxacin Susceptibility Testing Interpretive Criteria and Quality Control Guidelines for Dilution and Disk Diffusion Methods K. C. KuglerR. N. Jonesthe Quality Control Study Group Poster Presentations 01 December 2012 Pages: 176 - 177